Долгая жизнь с муковисцидозом. Коллектив авторов
Чтение книги онлайн.
Читать онлайн книгу Долгая жизнь с муковисцидозом - Коллектив авторов страница 30
![Долгая жизнь с муковисцидозом - Коллектив авторов Долгая жизнь с муковисцидозом - Коллектив авторов](/cover_pre303403.jpg)
238
Tullis DE, Burns JL, Retsch-Bogart GZ, et al. Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: a placebo-controlled trial. J Cyst Fibros 2014; 13: 296–305.
239
Horsley A, Jones AM. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev 2012; 10: CD009529.
240
Cystic Fibrosis Foundation. Patient registry annual data report 2012. Bethesda: Cystic Fibrosis Foundation; 2012. http://www.cff.org/UploadedFiles/research/Clinical Research/PatientRegistryReport/2012-CFF-Patient-Registry.pdf
241
Emerson J, McNamara S, Buccat AM, et al. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008, Pediatr Pulmonol 2010; 45: 363-70.
242
Ridderberg W, Bendstrup KE, Olesen HV, et al. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 2011; 10:466-9.
243
Hansen CR, Pressler T, Ridderberg W, et al. Achromobacter species in cystic fibrosis: crossinfection caused by indirect patient-to-patient contact. J Cyst Fibros 2013; 12:609-15.
244
Ronne Hansen C, Pressler T, H0iby N, et al. Chronic infection with Achromobacter xylosoxidans'm cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 2006; 5: 245-51.
245
Amoureux L, Bador J, Siebor E, et al. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. J Cyst Fibros 2013; 12: 170-6.
246
Jakobsen TH, Hansen MA, Jensen P0, et al. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One 2013; 8: e68484.
247
Raso T, Bianco O, Grosso B, et al. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 2008; 116: 837-11.
248
Moissenet D, Baculard A, Valcin M, et al. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis 1997; 24: 274-5.
249
Kanellopoulou M, Pournaras S, Iglezos H, et al. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis 2004; 23: 336-9.
250
Hansen C, Pressler T, H0ibyN,et al. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 2006;5:245-51.
251
Magni A, Trancassmi M, Varesi P, et al. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients. J Clin Microbiol 2010; 48:1035-9.
252
Trancassini M, lebba V, Citera N, et al. Outbreak of Achromobarter xylosoxidans'm an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front Microbiol 2014; 5: 138.
253
Magni A, Trancassmi M, Varesi P, et al. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients. J Clin Microbiol 2010; 48:1035-9.
254
European Cystic Fibrosis Society. ECFS patient registry. Annual data report 2010. Karup: European Cystic Fibrosis Society; 2010. https://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFSPR_Report10_v12014_final_020617.pdf
255
Coenye T Falsen E, Hoste B, et al. Description of Pandoraeagen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensiscomb. nov. Int J Syst Evol Microbiol 2000; 50(Pt 2): 887-99.
256
Atkinson RM, LipumaJJ, Rosenbluth DB, et al. Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR. J Clin Microbiol 2006; 44: 833-6.
257
Costello A, Herbert G, Fabunmi L, et al. Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells. J Med Microbiol 2011; 60(Pt 3): 289-99.
258
Jorgensen IM, Johansen HK, Frederiksen B, et al. Epidemic spread of Pandoraea apista,a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol 2003; 36: 439-16.
259
Coenye T, Goris J, Spilker T, et al. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosusgen. nov, sp. nov, J Clin Microbiol 2002; 40: 2062-9.
260
Bittar F, Richet H, Dubus JC, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 2008; 3:e2908.
261
Bittar F, Richet H, Dubus JC, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 2008; 3:e2908.
262
Bittar F, Leydier A, Bosdure E, et al. Inquilinus limosus and cystic fibrosis. Emerg Infect Dis 2008; 14:993-5.
263
Bittar F, Richet H, Dubus